Treatment of inflammatory lung disease and therapeutic agents useful therefor

TW202641848APending Publication Date: 2026-10-16F HOFFMANN LA ROCHE & CO AG
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
TW114149842
Authority / Receiving Office
TW · TW
Patent Type
Applications
Current Assignee / Owner
Priority Date
2024-12-19
Filing Date
2025-12-18
Publication Date
2026-10-16

Smart Images

  • Figure TWG2TA001080728_001
    Figure TWG2TA001080728_001
  • Figure TWG2TA001080728_002
    Figure TWG2TA001080728_002
  • Figure TWG2TA001080728_003
    Figure TWG2TA001080728_003
Patent Text Reader

Abstract

The present invention generally relates to the treatment of inflammatory lung disease, particularly chronic obstructive pulmonary disease (COPD), and to therapeutic agents useful therefor. In particular, the present invention relates to antibodies, including bispecific antibodies, useful for the treatment of inflammatory lung disease. In addition, the invention relates to polynucleotides encoding such antibodies, vectors and host cells comprising such polynucleotides, as well as methods for producing such antibodies.
Need to check novelty before this filing date? Find Prior Art